APA (7th ed.) Citation

R, W. (2026). Evaluation of OATP1B inhibitory potential using an endogenous biomarker coproporphyrin-I in new drug applications: Case reports submitted by 2024. Drug metabolism and pharmacokinetics, 66, 101513. https://doi.org/10.1016/j.dmpk.2025.101513

Chicago Style (17th ed.) Citation

R, Watari. "Evaluation of OATP1B Inhibitory Potential Using an Endogenous Biomarker Coproporphyrin-I in New Drug Applications: Case Reports Submitted by 2024." Drug Metabolism and Pharmacokinetics 66 (2026): 101513. https://doi.org/10.1016/j.dmpk.2025.101513.

MLA (9th ed.) Citation

R, Watari. "Evaluation of OATP1B Inhibitory Potential Using an Endogenous Biomarker Coproporphyrin-I in New Drug Applications: Case Reports Submitted by 2024." Drug Metabolism and Pharmacokinetics, vol. 66, 2026, p. 101513, https://doi.org/10.1016/j.dmpk.2025.101513.